Relationships among apolipoprotein A1 gene polymorphism, lipid levels and coronary atherosclerosis disease

Chinese Medical Journal

Volumn 116, Issue 5, 2003, Pages 665-668

  Zou, Yangchun ^a   Hu, Dayi ^b   Yang, Xinchun ^a   Jia, Xingyuan ^a   Wang, Lefeng ^a   Cui, Liang ^a   Liu, Xiaohui ^a   Gao, Mingming ^a   Wei, Yu ^a   Xu, Zhimin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Apo A1; Atherosclerosis; Lipids; Polymorphisms

Indexed keywords

ADENINE; APOLIPOPROTEIN A1; CYTOSINE; GUANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TYROSINE;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RISK ASSESSMENT;

APOLIPOPROTEIN A-I; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0038510101     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vega GL, Grundy SM. Hypoalphalipoproteinemia as a risk factor for coronary heart disease. Curr Opin Lipidol 1996;7: 209-216.
2. Braschi S, Coffill. CR, Neville TAM, et al. Effect of acylglyceride content on the structure and function of reconstituted high density lipoprotein particles. J Lipid Res 2001;42:79-87.
3. DeBeer MC, Durbin DM, Cai L, et al. Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI. J Lipid Res 2001 ;42:309-313.
4. Sparks DL, Frank PG, Braschi S, et al. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles. Biochemistry 1999;38:1727-1735.
5. Roosbeek S, Vanloo B, Duverger N, et al. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin: cholesterol acyltransferase. J Lipid Res 2001 ;42:31-40.
6. Frank PG, Marcel YL. Apolipoprotein A-I structure-function relationships. J Lipid Res 2000;41:853-872.
7. Durbin DM, Jonas A. Lipid-free apolipoproteins A-I, and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase. J lipid Res 1999;40:2293-2302.
8. Rgeuero JR, Cubero GI, Batalla A, et al. Apolipoprotein AI gene polymorphisms and risk of early coronary disease. Cardiology 1998;90:231-235.
9. Ozturk IC, Killeen AA. An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk. Arch Pathol Lab Med 1999; 123:1219-1222.
10. Zaragoza ( L144R). Atherosclerosis 2001; 154:613-623.
11. Oscar PM, Eric B, Guido F, et al. Metabolism of apolipoproteins A-I and A-II in subjects carrying similar apo A-I, mutations, apo A-I Milano and apo A-I Paris. Atherosclerosis 2000;148;317-326.
12. Lee M, Uboldi P, Giudice D, et al. Identification of domains in Apo A-I susceptible to proteolysis by mast cell chymase: implications for HDL function. J Lipid Res 2000; 41: 975-984.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasms, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-503.
14. Karnboh MI, Rewers M, Aston CE, et al. Plasma apolipoprotein A-I, apolipoprotein B and lipoprotein (a) concentrations in normoglycemic Hispanics and non-Hispanics whites form the San Luis Valley, Colorado. Am J Epidemiol 1997;146:1011-1023.
15. Borque L, Maside C, Iglesias A. Automated turbidimetry of serum Lp(a). Eur J Clin Chen Clin Biochem 1993;32:127-130.
16. Wang XL, Liu SX, McCredie RM, et al. Polymorphisms at the 5'-end of the apolipoprotein A1 gene and severity of coronary artery disease. J Clin Invest 1996;98:372-377.
17. Hingorani AD. Polymorphisms in endothelial nitric oxide synthase and atherogenesis. Atherosclerosis 2001 ; 154: 521-527.
18. Barre DE, Guerra R, Verstraete R, et al. Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels. J Lipid Res 1994;35:1292-1296.
19. Wang XL, Badenhop R, Humphrey K, et al. New MspI polymorphism at + 83 bp of the human apolipoprotein A-I gene: association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol 1996; 13: 1-10.
20. Miller M, Aiello D, Pritchard H, et al. Apolipoprotein A-I (Zaval1a) (Leu159→pro) , HDL cholesterol deficiency in a kindred associated with premature coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18:1242-1247.
21. Fin Dominantly inherited hypoalphalipo-proteinemia due to a single base substitution in the apolipoprotein A-I gene. Arterioscler Thromb Vasc Biol 1997;17:83-90.
22. Kee FP, Amouyel F, Arveiler D, et al. Lack of association between genetic variations of apoA-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study . Atherosclerosis 1999;145:187-195.
23. Chakravarti A. Population genetics-making sense out of sequence. Nat Genet 1999;21:56-60.
24. Cho KH, Durbin DM, Jonas A. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin: cholesterol acyltransferase and in HDL rearrangements. J Lipids Res 2001;42:379-389.
25. Cho KH, Jonas A. A key point mutation (V156E) affects the structure and functions of human apolipoprotein A-I. J Biol Chem 2000;275:26821-26827.